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Periodontitis is affecting over half of the adult population, and represents a major public health 
problem. Previously, we isolated a subset of gingival fibroblasts (GFs) from periodontitis patients, 
designated as periodontitis-associated fibroblasts (PAFs), which were highly capable of collagen 
degradation. To elucidate their molecular profiles, GFs isolated form healthy and periodontitis-affected 
gingival tissues were analyzed by CAGE-seq and integrated with the FANTOM5 atlas. GFs from healthy 
gingival tissues displayed distinctive patterns of CAGE profiles as compared to fibroblasts from other 
organ sites and characterized by specific expression of developmentally important transcription factors 
such as BARX1, PAX9, LHX8, and DLX5. In addition, a novel long non-coding RNA associated with LHX8 
was described. Furthermore, we identified DLX5 regulating expression of the long variant of RUNX2 
transcript, which was specifically active in GFs but not in their periodontitis-affected counterparts. 
Knockdown of these factors in GFs resulted in altered expression of extracellular matrix (ECM) 
components. These results indicate activation of DLX5 and RUNX2 via its distal promoter represents 
a unique feature of GFs, and is important for ECM regulation. Down-regulation of these transcription 
factors in PAFs could be associated with their property to degrade collagen, which may impact on the 
process of periodontitis.
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Periodontitis is characterized by gingival inflammation accompanied by loss of supportive connective tissues 
for the tooth, resulting in impaired attachment of the periodontal ligament to the cementum. Periodontitis is 
one of the most common diseases in humans that affects over half of the adult population. Tooth loss caused by 
periodontitis is associated with masticatory dysfunction and poor nutritional status, and the medical cost for 
periodontitis and related diseases is an escalating burden to the healthcare economy1. The goal of conventional 
treatments for periodontitis has been to control the infection of gingival tissues; however, many cases of perio-
dontitis are resistant or refractory to antimicrobial therapies including antibiotics, antimicrobial mouth rinse, and 
removal of dental plaque2.
Beyond the conventional view of periodontitis as an infectious disease, an increasing number of studies focus 
on the aberration of cellular responses in the periodontitis-affected gingival tissues. Several studies have per-
formed comprehensive transcriptome analyses of the gingival tissues of periodontitis patients3–5, which improved 
our understanding of the molecular mechanisms underlying the pathogenesis of periodontitis3. However, these 
analyses provided little information on the cellular level, and it remained unknown which definite cell type is 
critical for the altered gene expression profiles in periodontitis.
A hallmark of periodontitis is degradation of extracellular matrices (ECM), such as collagen, between the 
tooth root and the alveolar bone. In various organs, the fibroblast is a central player to form the structural frame-
work and control tissue repair by regulating ECM turnover and remodeling. Gingival fibroblasts play important 
roles not only in the homeostasis of gingival tissue architecture but also in the pathogenesis of periodontitis2. 
Recently, we isolated and characterized a subset of gingival fibroblasts derived from periodontitis-affected 
patients that were designated as periodontitis-associated fibroblasts (PAFs), and demonstrated that they were 
highly capable of collagen degradation6,7.
Preventing ECM degradation in supportive connective tissues for the tooth seems a straightforward thera-
peutic approach for periodontitis. As a proof of concept, we have previously demonstrated that targeting PAFs by 
inhibition of key signaling pathways, i.e., transforming growth factor-β (TGF-β ) and vascular endothelial growth 
factor (VEGF), successfully protected PAF-mediated degradation of collagen in experimental models of perio-
dontitis6,7. Obviously, it is important to elucidate the PAF phenotype from diagnostic and therapeutic viewpoints; 
however, the molecular mechanisms how PAFs appear and contribute to ECM degradation in the periodontitis 
tissues are largely unknown.
To further characterize and dissect the molecular repertoire of PAFs we took advantage of the ongoing project 
of the Functional annotation of the mammalian genome (FANTOM) 5. FANTOM 5 is an international research 
consortium that has released transcriptome data for about one thousand human samples including cell lines, pri-
mary cells, and tissues, using the cap analysis of gene expression (CAGE) technology, which captures the 5′ end 
of capped transcripts and sequences around 27 base pairs8. CAGE analysis allowed us to map transcription start 
sites and promoter regions both for coding and non-coding transcripts across the whole genome, simultaneously 
providing a quantitative measure of transcriptional activity among the numerous FANTOM5 samples9,10.
As part of the FANTOM5 project, we performed CAGE analyses on primary cultured human gingival 
fibroblasts, periodontal ligament fibroblasts, gingival epithelial cells, and epithelial cell rests of Malassez11. 
Furthermore, CAGE profiles of PAFs were also examined together with patient-matched gingival fibroblasts 
derived from healthy gingival tissues, helping us to identify specific molecular features and novel markers that are 
potentially of functional relevance7.
First we investigated if gingival fibroblasts have molecular characteristics distinct from fibroblasts derived 
from other organs as suggested by a previous report12. Next we compared CAGE profiles of PAFs and normal 
counterparts to examine gene expression patterns related to the PAF phenotype. Through these analyses we dis-
covered that the expression of Distal-Less Homeobox 5 (DLX5) and Runt-related transcription factor 2 (RUNX2) 
in its long transcript form is specific for gingival fibroblasts, and is virtually lost in PAFs. Further transcrip-
tome analyses revealed that these identified genes are involved in the regulation of ECM. Our findings supported 
the hypothesis that altered molecular signals mediated by DLX5 and RUNX2 long form are associated with the 
aggressive phenotype of PAFs and degradation of ECM.
This work is part of the FANTOM5 project. Data downloads, genomic tools, and co-published manuscripts 
are summarized online at http://fantom.gsc.riken.jp/5/.
Result
Distinctive CAGE profiles of gingival fibroblasts. A previous study has shown that human fibroblasts 
derived from different sites of the body display differential gene expression patterns12, highlighting the hetero-
geneity of fibroblasts. In order to define transcriptional profiles characteristic for gingival fibroblasts (GFs) in 
comparison with other fibroblasts, the CAGE data of totally 45 primary cultured fibroblasts derived from different 
anatomic sites were extracted from the FANTOM5 database (Supplementary Table S1). These samples included 
6 gingival fibroblast (GF) cultures (GF1, GF2, and GF3 were commercially available; GF4, GF5, and GF6 were 
established and provided by us) and six periodontal ligament fibroblast (PLF) cultures (PLF1, PLF2, and PLF3 
were commercially available; PLF4, PLF5, and PLF6 were established and provided by us).
Unsupervised hierarchical clustering with all DPIs revealed that primary cultures of GF and PLF established 
in our institute were grouped together (Fig. 1(a)). On the other hand, the commercially available GFs and PLFs 
were grouped into two separate clusters. Comparison of CAGE profiles between GFs and PLFs did not show any 
significant difference (data not shown), indicating GFs and PLFs have similar CAGE profiles.
CAGE peaks represent transcription start sites (TSSs), and their profiling is useful to identify the locations and 
usage levels of TSSs. We can thereby evaluate expression levels of transcripts and promoter activities across the 
whole genome. To describe the CAGE profiles of GFs, CAGE tag counts of all 6 GFs were compared to those of 
all other 33 fibroblasts except PLFs. In total 3633 CAGE-defined promoters showed significantly higher expres-
sion, while 514 promoters displayed lower expression (FDR < 0.05, Supplementary Table S3). First we aimed to 
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Figure 1. (a) Hierarchical clustering analysis with all DPIs of 6 gingival fibroblasts (GFs) (red), 6 periodontal 
ligament fibroblasts (PLFs) (blue), and 33 other fibroblasts derived from different anatomic sites (green) by 
Ward’s method. The details of fibroblasts are described in Supplementary Table S1. Red to yellow color gradient 
of heatmap represents the degree of correlation of the indicated cell pair. (b) MA plot showing expression 
differences between GFs and 33 other fibroblasts. Red marks indicate promoters with significantly differential 
expression defined by false discovery rate (FDR) < 0.05, and blue marks indicate the genes with highly 
differential expression after sorting by FDR. The x-axis represents expression strength of a gene measured by 
CAGE tag counts and shown as average log2 counts per million. The y-axis represents fold changes of gene 
expression shown as log2 values. Positive fold changes indicate higher expression in GFs. (c) Venn diagram 
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investigate gene-wise expression differences and focused on CAGE-defined promoters annotated as peak 1 (p1) 
which shows the highest expression among alternative promoters for the same gene. As a result, as much as 195 
and 109 p1 promoters showed higher and lower expression, respectively, by the strict criteria as follows; log2 fold 
change > 2 or < − 2, log2 counts per million > 1, and matching single gene annotation (Supplementary Table S4). 
Differential gene expression was further illustrated in MA-plot, which showed the relationship between the 
magnitude of differential expression (fold change) and average expression level of each gene of 39 all fibroblasts 
(Fig. 1(b)). To predict the function of differentially expressed genes in GFs, GO analysis was performed. The pre-
dicted functions of the 195 genes enriched in GFs were related to organ development and many genes represented 
transcription factors (Supplementary Table S5, Supplementary Figure S1(a)).
Notably, highly expressed genes in GFs included BarH-Like Homeobox 1 (BARX1), Paired Box 9 (PAX9), 
Lim Homeobox 8 (LHX8), Distal-Less Homeobox 1 (DLX1), DLX2, DLX5, and Msh Homeobox 1 (MSX1), all of 
which have been shown as master regulators of mesenchymal cells during the tooth development13. These find-
ings may indicate that adult GFs maintain key transcriptional features involved in odontogenesis as ‘positional 
memory’ and that these genes are still of relevance to maintain tissue homeostasis12. Since regulatory mechanisms 
of tissue repair and regeneration have similarities with those for development and organogenesis, our findings 
suggested the potential roles of key transcription factors in the pathogenesis of periodontitis.
In analogy, many genes that showed lower expression in GFs were transcription factors. The functions of the 
109 genes with lower expression in GFs predicted by GO analysis were also associated with organ development 
(Supplementary Table S6, Supplementary Figure S1(b)). Interestingly, GFs showed extremely low expression 
levels of homeotic (HOX) genes crucial for body positioning during development, such as HOXB2, HOXB4, 
HOXB7, HOXC8, HOXC9, and HOXD8, as compared to other fibroblasts14. Expression profiling of all HOX genes 
showed that GFs do not express any Hox gene while a subset of HOX genes are expressed in other fibroblasts 
(Supplementary Figure S2(a)). These findings further supported the notion that GFs represent a unique cell pop-
ulation distinct from other fibroblasts.
To validate the findings based on the FANTOM5 dataset, 3 microarray datasets which evaluated various 
fibroblasts including GFs were analyzed focusing on GFs12,15,16. Differential gene expression was determined fol-
lowing the criteria, FDR < 0.05 and log2 fold change > 1 or < − 1. Through the analyses on GSE3551 (4 GFs vs 
46 others), GSE19090 (6 GFs vs 33 others), and GSE22029 (8 GFs vs 8 dermal fibroblasts) datasets, 595, 151, 
and 314 genes were found to be significantly enriched in GFs, respectively (Supplementary Table S7). Heatmaps 
of the top 150 genes with significantly differential expression between GFs and other fibroblasts are shown in 
Supplementary Figure S2(b). Furthermore, 9 genes showed higher expression in GFs commonly across these 3 
datasets (Fig. 1(c)). Among them, 5 genes also showed significantly higher expression in GFs in the FANOM5 
database (Supplementary Table S4). These robust GF-specific genes were BARX1, Proenkephalin (PENK), DLX5, 
PAX9, and SIX Homeobox 1 (SIX1) (Fig. 1(c)).
Among the genes that showed specific expression in GFs, we selected several genes that encode key transcrip-
tion factors for RT-qPCR validation. Consistent with the finding of CAGE profiles, BARX1, LHX8, and PAX9 
were confirmed to be specifically expressed in GFs as compared with lung fibroblasts (LFs) and dermal fibroblasts 
(DF) (Fig. 1(d)). In contrast, HOXB2 and Meis Homeobox 1 (MEIS1), both underexpressed in the FANTOM5 
dataset, were not detected in GFs while expressed in LFs and DF (Fig. 1(e)).
CAGE revealed activation of alternative promoter of RUNX2 in GFs. CAGE analysis provides 
definitive information of alternative promoters. In addition to comparative analyses of gene-wise expression 
(Supplementary Table S4), we also analyzed promoter-level expression differences between GFs and other fibro-
blasts to identify alternative promoters specific for GFs (Supplementary Table S3). We noted different expression 
patterns of transcript variants for RUNX2, a master regulator of osteoblast differentiation and bone formation17. 
Importantly, it has previously been shown that DLX5 specifically transactivates the RUNX2 distal promoter to 
confer cell type-specific expression of RUNX2 isoforms18. Since DLX5 is a robust GF-specific gene identified by 
our comparative analyses on the FANTOM5 CAGE profiles as well as 3 different microarray datasets (Fig. 1(b,c)), 
we further studied the associations between DLX5 and RUNX2 alternative promoters in GFs and 33 other fibro-
blasts. We used the FANTOM5 ZENBU genome browser for CAGE validation19, and confirmed that the CAGE 
peak of p1 DLX5 appears specifically in GFs (Fig. 2(a)).
Among the transcript variants of RUNX2, long forms (NM_001015051 and NM_001024630) are transcribed 
from distal p1 promoter while a short form (NM_004348) uses proximal p2 promoter (Fig. 2(b)). We found that 
p1 RUNX2 was highly expressed in GFs indicating that RUNX2 long form is specifically transcribed in GFs. In 
contrast, RUNX2 short form, transcribed from p2 RUNX2, appeared ubiquitously expressed both in GFs and 
other fibroblasts (Fig. 2(b)).
of genes with higher expression in GFs compared to other fibroblasts. The results from 3 microarray datasets 
were merged (GSE3551, GSE19090, GSE22029). The number of genes with higher expression in GFs (log2 fold 
change > 1, FDR < 0.05) is indicated in parenthesis. The indicated 9 genes were common in the 3 datasets. 
Among them, 5 genes highlighted in red were also enriched in GFs as determined by CAGE profiling (b).  
(d) RT-qPCR for BARX1, LHX8, and PAX9 in GFs (black bars: GF4 and GF5), dermal fibroblasts (DF, grey 
bar: NB1RGB), and lung fibroblasts (LFs, white bars: NHLF, WI38, and HFL1). The expression of each gene 
was normalized to that of GAPDH. Bars represent mean ± SD. No CT indicates the failure to calculate Ct 
(cycle threshold) values due to undetectable expression. (e) RT-qPCR for MEIS1 and HOXB2 in GFs, DF, and 
LFs. The data is presented as in (d).
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To validate these findings, RT-qPCR for DLX5, RUNX2 long and short forms were performed. Primers for 
RUNX2 long form were designed in a way that one half hybridizes to the second exon and the other half to the 
third exon. Primers for RUNX2 short form were designed to amplify the isoform-specific sequence of the first 
exon. Consistent with the finding of CAGE analysis, RUNX2 long form was specifically detected in GFs whereas 
the expression of RUNX2 short form was confirmed both in GFs and other fibroblasts (Fig. 2(c)).
CAGE identified novel GF-specific non-coding RNAs. Accumulating evidence demonstrates that more 
than 60% of the genome is transcribed as RNA, and most of the transcripts are non-coding RNAs (ncRNAs)20–22. 
The CAGE technique used in the FANTOM5 project allows the analysis of both coding and non-coding tran-
scripts. We also compared CAGE peaks for ncRNAs between GFs and other fibroblasts (FDR < 0.05, log2 fold 
change > 2 or < − 2, and log2 counts per million > 1), and found that 34 and 16 ncRNAs showed significantly 
higher and lower expression in GFs, respectively (Supplementary Table S8).
Figure 2. (a) CAGE peaks of 6 GFs and 33 other fibroblasts visualized by the ZENBU browser. Genomic 
coordinate and transcript of DLX5 registered in RefSeq (NM_005221) are shown on the top. CAGE peak for p1 
DLX5 is prominent in GFs in contrast to 33 other fibroblasts. (b) CAGE peaks of 6 GFs and 33 other fibroblasts 
visualized by the ZENBU browser. Genomic coordinate and 3 protein coding transcript variants of RUNX2 
registered in RefSeq (NM_004348, NM_001015051, and NM_001024630) are shown on the top. CAGE peaks 
for both p1 RUNX2 and p2 RUNX2 are detected in GFs while other fibroblasts show a dominant peak for 
p2 RUNX2. (c) RT-qPCR for DLX5, RUNX2 long form transcribed from p1 RUNX2 promoter, and RUNX2 
short form transcribed from p2 RUNX2 promoter. Primers for RUNX2 long form were designed so that one 
half hybridizes to the second exon and the other half to the third exon. Primers for RUNX2 short form were 
designed to amplify the isoform-specific sequence of the first exon. The expression of each gene was normalized 
to that of GAPDH. Bars represent mean ± SD.
www.nature.com/scientificreports/
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The ncRNA with TSS at chr1:75599683-75599699 on the minus strand showed the most specific expression 
in GFs (FDR = 1.38 × 10−82). Notably, this CAGE peak is located within 1,000 bp of the TSS of LHX8 (Fig. 3(a), 
Supplementary Table S8), a GF-specific coding gene identified by our comparative analysis. The colocalization 
and parallel expression patterns in GFs suggested that transcription of this ncRNA might be associated with the 
state of chromatin and LHX8 gene expression (Supplementary Figure S3).
To supplement the CAGE analysis on TSSs with sequence information, we further performed RNA-seq. 
Combined analyses of RNA-seq and CAGE data revealed that the newly identified TSS is for long non-coding 
RNAs (lncRNAs) that share the first exon and have several splicing variants. We designated these transcripts 
as lnc-LHX8 (Fig. 3(a)). In order to validate the distinctive expression of lnc-LHX8 in GFs, specific primers for 
lnc-LHX8 were designed to amplify the first exon, and RT-qPCR was performed. Consistent with the findings of 
CAGE and RNA-seq analyses, transcripts for lnc-LHX8 were exclusively detected in GFs, indicating the highly 
specific expression (Fig. 3(b)).
Collectively, analyses on the CAGE profiles of GFs as compared to other fibroblasts delineated the unique 
transcriptional patterns of coding genes, alternative promoters, and ncRNAs.
Distinctive CAGE profiles of PAFs. In the following analyses, we focused on gingival fibroblasts derived 
from patients suffering from periodontitis. Three pairs of patient-matched gingival fibroblasts were isolated from 
periodontitis-affected and healthy gingival tissues, and designated as periodontitis-associated fibroblasts (PAFs) 
and non-periodontitis-associated fibroblasts (non-PAFs). Consistent with our previous report7, PAFs induced 
collagen degradation more strongly than non-PAFs in an established three-dimensional co-culture model of 
periodontitis (Fig. 4(a)). H&E staining of collagen gels showed degradation of collagen matrix adjacent to PAFs 
Figure 3. (a) RNA-seq of GF8 (lower panel) and CAGE peak of GF4 (upper panel). LHX8 and neighboring 
ncRNAs which are specifically expressed in normal GFs were visualized by the ZENBU browser. (b) RT-qPCR 
for lnc-LHX8 in GFs (GF4, GF5, GF7, and GF8) and other fibroblasts (DF and LFs). The expression was 
normalized to that of GAPDH. Bars represent mean ± SD.
www.nature.com/scientificreports/
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(Fig. 4(b)). To explore transcriptional profiles underlying the functional differences between PAFs and non-PAFs, 
CAGE analysis was performed using the RNA samples of these primary cultured fibroblasts derived from perio-
dontitis patients.
Hierarchical clustering with all DPIs of PAFs, non-PAFs, and normal GFs revealed that both PAFs and 
non-PAFs tended to be grouped into the same cluster (Fig. 5(a)). Next we explored promoter-level expression 
differences between PAFs and non-PAFs, and identified 112 up-regulated and 46 down-regulated promoters, 
including alternative promoters for the same genes (FDR < 0.1) (Fig. 5(b), Supplementary Table S9). Analyses of 
transcriptional differences at gene expression level revealed 48 up-regulated and 19 down-regulated coding genes 
in PAFs (Supplementary Table S10).
GO analysis showed that up-regulated genes in PAFs were involved in signal transduction such as interleukin 
32 (IL32), chemokine (C-X-C motif) ligand 1 (CXCL1), epiregulin (EREG), and secreted frizzled-related pro-
tein 2 (SFRP2), regulation of immune effector process such as complement component 3 (C3), and dipeptidyl 
peptidase-4 (DPP4), and cell adhesion such as intercellular adhesion molecule 1 (ICAM1), cadherin 18 (CDH18), 
and claudin 1 (CLDN1) (Supplementary Table S11, Supplementary Figure S4).
We supplemented the CAGE analysis of PAFs with publicly available microarray datasets from 241 perio-
dontitis and 69 healthy gingival tissue samples (GSE16134)3. The 48 up-regulated genes from the GAGE anal-
ysis of PAFs (Supplementary Table S10, hereafter referred to as PAF-related genes) were also significantly 
enriched in the periodontitis tissues (FDR < 0.05) (Fig. 5(c)). Among them, seven genes with the highest 
association were CXCL1, matrix metalloproteinase-3 (MMP3), prostaglandin D2 synthase (PTGDS), SFRP2, 
EGF-TM7-Latrophilin-Related protein (ELTD1), IL32, and ICAM1. The heatmap of 37 genes which could be 
annotated both in the CAGE and GSE16134 datasets are shown in Fig. 5(d).
CAGE revealed inactivation of DLX5 and RUNX2 distal promoter in PAFs. Next we analyzed the 
46 down-regulated promoters in PAFs (Supplementary Table S9). Remarkably, 12 out of 46 down-regulated pro-
moters were listed as those specifically up-regulated in GFs (Supplementary Table S3), which were p1 DLX5, p2 
DLX5, p1 RUNX2, p24 RUNX2, p1 PENK, p3 PENK, p1 SYTL2, p2 COL10A1, p2 LAMP5, p2 PLEKHA5, p1 
CBLN2, and p chr16:86532148 - 86532166-. Among 19 down-regulated genes in PAFs (Supplementary Table S10), 
4 genes (DLX5, RUNX2, PENK, and SYTL2) were listed as those highly expressed in GFs (Supplementary 
Table S4), indicating that the GF-specific transcriptional pattern is modulated in PAFs. The detailed compara-
tive analysis of the CAGE peaks between PAFs and non-PAFs confirmed the loss of GF-specific promoters, p1 
DLX5 (Fig. 6(a), Supplementary Figure S5(a)) and p1 RUNX2 in PAFs (Fig. 6(b), Supplementary Figure S5(a)). 
Meanwhile, the expression of RUNX2 short form (p2 RUNX2) was not different between PAF and non-PAFs 
(Fig. 6(b), Supplementary Figure S5(a)). Although there were some variations in expression due to the hetero-
geneity of primarny cultured GFs, we confirmed the differential expression of DLX5 and RUNX2 long form by 
RT-qPCR in 3 pairs of patient-matched PAFs and non-PAFs, additional two independent PAFs, and 4 normal GFs 
(Fig. 6(c)). In contrast, RUNX2 short form transcribed from p2 RUNX2 did not show clear differences among 







Figure 4. (a) Collagen gels embedded with patient-matched periodontitis-associated fibroblasts (PAFs) or 
non-PAFs derived from healthy gingival tissues. Gingival epithelial cells, which are not patient-matched, were 
co-cultured on the surface of each gel for 5 d. Representative pictures of collagen gels cultured separately under 
air-liquid interface conditions. The brown spot in each well is the remaining collagen gel. The size of collagen 
gel embedded with PAFs was smaller than that seen in the non-PAF treatment. (b) Representative pictures of 
hematoxylin and eosin (H&E) staining of collagen gels embedded with PAFs or non-PAFs. Arrows indicate 
degradation of collagen gel matrix adjacent to PAFs. Bar represents 25 μ m.
www.nature.com/scientificreports/
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Figure 5. (a) Hierarchical clustering analysis with all DPIs of PAFs (PAF1, PAF2, PAF3, and PAF4), non-
PAFs (non-PAF1, non-PAF2, and non-PAF3), and control GFs (GF1, GF2, GF3, GF4, GF5, and GF6) by 
Ward method. Red to yellow color gradient of heatmap represents the degree of correlation of the indicated 
cell pair. (b) MA plot showing expression differences between 3 patient-matched PAFs and non-PAFs. Red 
marks indicate genes (p1 promoters) with significantly differential expression defined by false discovery rate 
(FDR) < 0.1, and blue marks indicate the genes with highly differential expression after sorting by FDR. The 
x-axis represents expression strength of a gene measured by CAGE tag counts and shown as average log2 
counts per million. The y-axis represents fold changes of gene expression shown as log2 values. Positive fold 
changes indicate higher expression in PAFs. (c) Gene set enrichment analysis (GSEA) reveals the enrichment 
of 48 “PAF-related genes” in periodontitis tissues (n = 241) compared to healthy gingival tissues (n = 69) 
from GSE16134. The genes that correlated with the periodontitis and healthy phenotypes are indicated on the 
left (‘Periodontitis-high’) and right (‘Healthy-high’), respectively. The seven leading edge genes are indicated 
with an arrow. (d) Heatmap representing the relative expression levels of 37 “PAF-related genes” which could 
be annotated both in the CAGE and GSE16134 datasets. The seven leading edge genes identified in (c) are 
highlighted. Red to blue color gradient of heatmap represents the relative gene expression levels.
www.nature.com/scientificreports/
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A previous report showed that DLX5 specifically transactivates the RUNX2 distal promoter, which subse-
quently regulates osteoblast differentiation18. Our findings suggested that DLX5 and RUNX2 long form are highly 
expressed in GFs similar to osteoblasts, and these promoter activities are lost in PAFs. To assess the similarities in 
Figure 6. (a) CAGE peaks of patient-matched 3 PAFs and 3 non-PAFs visualized by the ZENBU browser. 
Genomic coordinate and transcript of DLX5 registered in RefSeq (NM_005221) are shown on the top. CAGE 
peak for p1 DLX5 was observed in non-PAFs while absent in PAFs. (b) CAGE peaks of patient-matched 3 
PAFs and 3 non-PAFs visualized by the ZENBU browser. Genomic coordinate and 3 protein coding transcript 
variants of RUNX2 registered in RefSeq (NM_004348, NM_001015051, and NM_001024630) are shown on 
the top. CAGE peaks for both p1 RUNX2 and p2 RUNX2 are detected in non-PAFs as observed in control 
GFs (Fig. 2(b)) while PAFs show a dominant peak for p2 RUNX2. (c) RT-qPCR for DLX5 and RUNX2 long 
form transcribed from p1 RUNX2 promoter. The expression of each gene was normalized to that of GAPDH. 
Bars represent mean ± SD. The expression levels were examined in 4 control GFs (GF4, GF5, GF7, and GF8), 
3 patient-matched non-PAFs (non-PAF1, non-PAF2, and non-PAF3) and PAFs (PAF1, PAF2, and PAF3), 
and 2 additional PAFs (PAF4 and PAF5). Each expression was normalized to that of GAPDH. Bars represent 
mean ± SD.
www.nature.com/scientificreports/
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terms of transcriptional profiles among GFs, PLFs, PAFs, non-PAFs, and osteoblasts, we performed unsupervised 
hierarchical clustering of CAGE profiles of these cell types (Supplementary Figure S6(a)). Osteoblasts and gin-
gival fibroblasts were divided into distinct clusters, implying that transcriptional profiles between GFs and oste-
oblasts are largely different despite that DLX5 and RUNX2 distal promoters are preferentially activated in both 
cell types (Supplementary Figure S6(b)). Collectively, analyses on the CAGE data of PAFs highlighted the specific 
inactivation of DLX5 and RUNX2 distal promoters, which prompted us to explore the functional significance of 
these altered promoter activities.
Functional roles of DLX5 and p1 RUNX2 in gingival fibroblast. The functional roles of DLX5 and 
RUNX2 long form were evaluated by knockdown experiments using microRNAs targeting DLX5 and RUNX2 
long form (Supplementary Table S2). Normal gingival fibroblast, GF4, was selected for these experiments because 
it showed abundant expression of both genes (Fig. 6(c)). Efficient transduction (over 99%) was confirmed by 
detecting EmGFP fluorescence, and obvious changes in cell morphology or viability were not observed following 
lentiviral infection (Fig. 7(a)).
RT-qPCR revealed that DLX5 knockdown led to the down-regulation of RUNX2 long form, while the expres-
sion of RUNX2 short form was not influenced (Fig. 7(b)), suggesting that DLX5 preferentially transactivates the 
RUNX2 distal promoter as reported previously18. We could also selectively knockdown RUNX2 long form, and 
importantly, the expression of RUNX2 short form was not largely influenced by silencing of RUNX2 long form 
(Fig. 7(c)).
To explore the functional roles of DLX5 and RUNX2 distal promoters, comparative microarray analyses 
were carried out in GF4 following knockdown of DLX5 and RUNX2 long form. Affymetrix GeneChip® Human 
Genome U133 Plus 2.0 array was used, which contains six probes (216994_s_at, 221282_x_at, 221283_at, 
232231_at, 236858_s_at, and 236859_at) for RUNX2. Among them, target sequence of 236859_at is in the first 
exon and 5′ UTR, which is specific for RUNX2 long form transcribed from p1 RUNX2. Microarray results con-
firmed specific knockdown of RUNX2 long form as observed in RT-qPCR experiments. Transcriptional profiling 
of GF4 transduced with DLX5 miR #2 (Supplementary Table S12), DLX5 miR #4 (Supplementary Table S13), 
and RUNX2 miR #1 (Supplementary Table S14) revealed that 1133, 1026, and 1473 probes were down-regulated, 
respectively. Comparison between DLX5 miR #2 and DLX5 miR #4 showed 337 common probes, and surpris-
ingly, as much as 168 probes (151 genes) were commonly down-regulated by DLX5 miR #2, DLX5 miR #4, and 
RUNX2 miR #1 (Fig. 7(d), Supplementary Table S15), indicating that transcriptional regulations by DLX5 are 
largely mediated by the induction of RUNX2 long form. GO analysis revealed that these common genes are pre-
dominantly involved in ECM organization and cell adhesion, such as collagen (COL14A1, COL15A1, COL5A1, 
and COL8A2), elastin (ELN), matrilin 3 (MATN3), dermatopontin (DPT), fibrillin 2 (FBN2) and vascular cell 
adhesion molecule 1 (VCAM1) (Supplementary Table S15).
Taken together, activation of DLX5 and RUNX2 distal promoters represents the unique feature of GFs, and 
is important for ECM regulation. Down-regulation of these transcription factors in PAFs is likely to modify the 
expression of ECM proteins and cell adhesion, which might be involved in the pathogenesis of periodontitis.
Discussion
This study evaluates the transcriptional profiles of GFs and PAFs as their pathogenic counterparts, by CAGE 
sequencing as part of the FANTOM5 project. We compared GFs to human fibroblasts from other tissues, which 
revealed the transcriptional profiles of GFs for coding genes, alternative promoters, and ncRNAs. To our knowl-
edge, this is the first comprehensive characterization of the transcriptome characteristic for GFs.
Fibroblasts are ubiquitous mesenchymal cells that play important roles in development, tissue repair, and 
various diseases such as fibrosing diseases and cancers. In periodontitis, fibroblasts critically contribute to its 
pathology by producing inflammatory cytokines and altering gingival tissue architectures7. It has been reported 
that fibroblasts from different anatomic sites have characteristic gene expression patterns12,23. However, transcrip-
tional features of GFs distinct from other fibroblasts have not been investigated and remained largely unknown.
In the present study, we discovered that a subset of transcription factors such as BARX1, PAX9, LHX8 and 
DLX5, are highly expressed in GFs. It is noteworthy that these transcription factors are also active in mesenchymal 
cells during tooth development. Among them, DLX5 was found to be inactivated in PAFs derived from the adult 
periodontitis-affected gingival tissues. This finding implies that positional memory of development is maintained 
in GF, and loss of GF identity is linked to pathological activation of PAFs. Transcriptional profiling of PAFs showed 
that genes involved in signal transduction and immune response are up-regulated (Supplementary Table S11). 
Further studies are needed to elucidate which signals are linked to the loss of GF identity and acquisition of the 
PAF phenotype.
Of particular interest was specific activation of DLX5 and RUNX2 distal promoters in GFs and their inactiva-
tion in PAFs. This discovery was made possible by the CAGE technology that detects TSSs and promoter regions. 
It is well established that RUNX2 acts as a master regulator for osteoblast differentiation and bone formation in 
cell culture and animal models17. In humans, mutation of RUNX2 causes cleiocranial dysplasia and teeth abnor-
malities24. Although RUNX2 has been implicated with the tooth development, its role in GFs and periodontitis 
remains underexplored.
RUNX2 has 2 major isoforms which share a common 509-amino-acid sequence. RUNX2 short form has a dis-
tinctive 5-amino-acid N-terminal sequence that differs from the 19-amino-acid N-terminal sequence of RUNX2 
long form. These isoforms are functionally different as revealed by the studies of specific knockout mice25,26, 
while both are crucial in bone development27. The activation of RUNX2 distal promoter occurs during osteoblast 
differentiation and is necessary for maintaining the osteoblast phenotype. On the other hand, the activation of 
RUNX2 proximal promoter is ubiquitous both in non-osseous mesenchymal cells and osteoblast progenitors. A 
recent study revealed that transducing RUNX2 short form and some defined factors could cause direct conversion 
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Figure 7. (a) Control GF (GF4) was infected with lentiviruses carrying artificial miRNAs together with 
EmGFP. Over 99% of lentivirus-infected cells were positive for EmGFP that indicate highly efficient 
transduction of artificial miRNAs. Control cells were transduced with negative control miRNA (NC miR). 
For knockdown of DLX5 and RUNX2 long form, 4 different miRNA sequences for each transcript were designed 
(DLX5 miR #1 to #4, and RUNX2 long miR #1 to #4). The pictures of fluorescence microscopy for GF4 infected 
with lentiviruses carrying NC miR, DLX5 miR #2, and RUNX2 long miR #1 are shown. Scale bar indicates 
200 μ m. (b) RT-qPCR for DLX5, RUNX2 long form transcribed from p1 RUNX2 promoter, and RUNX2 short 
form transcribed from p2 RUNX2 promoter. RNA was collected 5 d after lentiviral infection. The expression of 
each gene was normalized to that of GAPDH. Bars represent mean ± SD. (c) RT-qPCR for RUNX2 long form 
transcribed from p1 RUNX2 promoter and RUNX2 short form transcribed from p2 RUNX2 promoter. RNA 
was collected 5 d after lentiviral infection. The expression of each gene was normalized to that of GAPDH. Bars 
represent mean ± SD. (d) Venn diagram of down-regulated genes (fold change < 0.5) by knockdown of DLX5 
miR #2, #4 and RUXN2 long miR #1.
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of human gingival fibroblasts into functional osteoblasts28. Furthermore, previous reports showed that inflamma-
tory reactions could decrease the expression levels of RUNX2 in periodontal ligament fibroblasts or osteoblasts 
in cellular models of periodontitis29, and DNA hypermeltylation was suggested to be a mechanism for RUNX2 
gene suppression in periodontal fibroblasts30. Studies on epigenetics might help understanding the regulation of 
RUNX2 promoter activities in gingival fibroblasts.
DLX5 is a homeobox transcription factor involved in bone development and fracture healing31. Mutation 
in DLX5 might be associated with split-hand/split-foot malformation32. It has been reported that DLX5 specif-
ically transactivates RUNX2 distal promoter in committed osteoblasts18. In accordance, the CAGE profiles of 
GFs showed that activation of DLX5 was concomitant with that of RUNX2 distal promoter (Figs 2 and 6). We 
established specific knockdown of DLX5 and RUNX2 long form without affecting the expression of RUNX2 short 
form. As anticipated, DLX5 knockdown led to down-regulation of RUNX long form whereas the expression of 
RUNX2 short form was not obviously altered. Noteworthy, the genes regulated by DLX5 and RUNX2 long form 
largely overlapped, further supporting the notion that DLX5 preferentially activates RUNX2 distal promoter and 
suggesting that the action of DLX5 is largely mediated by RUNX2 long form (Fig. 7(d)).
Given that activation of DLX5 and RUNX2 distal promoter is the distinctive feature of GFs, that is lost in PAFs, 
genes regulated by these factors are conceivably important for the homeostasis of gingival tissues. Knockdown of 
these factors and subsequent transcriptome analyses revealed that these factors regulate genes involved in ECM 
organization including collagen (COL14A1, COL15A1, COL5A1, and COL8A2), elastin, matrilin 3, dermatopon-
tin, and fibrillin 2.
In addition, small leucine-rich proteoglycans (SLRPs) were also found to be regulated by DLX5 and RUNX2 
long form, such as osteomodulin (OMD), asporin (ASPN), decorin (DCN), and osteoglycin (OGN). SLRPs are 
a group of proteins sharing various structural and functional similarities that have multiple roles in ECM reg-
ulation33. They are recently recognized as important regulators of cell-matrix crosstalk, influencing a variety of 
biological processes such as cell proliferation, differentiation, survival, adhesion, inflammation, angiogenesis, and 
tumorigenesis34.
Asporin is found to be expressed in periodontal ligaments35, which can bind to TGF-β 1 and inhibit its ability 
to induce cartilage matrix gene expression36,37. Decorin has also been reported to suppress TGF-β signaling and 
influence matrix organization38. We have previously demonstrated that TGF-β signaling is activated in PAFs 
and is a key mediator of gingival fibroblast-epithelial cell interaction6. Inhibition of TGF-β signaling clearly sup-
pressed collagen degradation in experimental models of periodontitis. Thus, our findings in the present study 
provide a clue to understanding the transcriptional network underlying the enhanced TGF-β signaling in PAFs. 
Further studies that explore matricellular functions of SLRPs, cell-matrix interactions, and TGF-β signaling acti-
vation processes would broaden our understanding of periodontitis.
In conclusion, CAGE profiling characterized distinctive transcriptional features of GFs and PAFs. Loss of 
GF identity appeared to be linked to the PAF phenotype, and DLX5-mediated alternative promoter activation of 
RUNX2 is crucial for ECM organization and homeostasis of the gingiva. Disruption of this signaling in PAFs may 
be involved in ECM degradation and impaired architecture of the gingiva of periodontitis. These findings provide 
novel insight into the molecular mechanisms how PAFs develop and contribute to progression of periodontitis.
Material and Methods
Cell culture. Isolation and cell culture of gingival fibroblasts from the healthy or periodontitis gingival tis-
sues were performed as described previously7,11,39. To minimize the risk of cell contamination from the bone, 
gingival tissues were incised under direct vision of the operator carefully. Gingival tissues were obtained during 
periodontal surgery at Nihon University School of Dentistry, Dental Hospital, Tokyo, Japan. All patients gave 
written informed consent. The protocol was approved by the Ethics Committee of Ohu University and Nihon 
University School of Dentistry. All experiments were performed in accordance with guidelines and regulations 
approved by the Research Ethics Committee of Ohu University and Nihon University School of Dentistry. The 
details of the gingival fibroblasts used in this study are shown in Supplementary Table S1. Human fetal lung fibro-
blasts (HFL1 and WI38) and adult normal human lung fibroblasts (NHLF) were obtained from American Type 
Culture Collection (ATCC) and Lonza (Basel, Switzerland), respectively. Normal dermal fibroblasts, NB1RGB, 
was obtained from RIKEN BRC (Tsukuba, Japan). All fibroblasts were cultured in DMEM supplemented with 
10% fetal bovine serum and 1% penicillin-streptomycin.
Three-dimensional co-culture of gingival epithelial cells and fibroblasts. Three-dimensional 
co-culture of gingival epithelial cells and fibroblasts were employed as an in vitro model of periodontitis according 
to the method described previously6,7,40. Collagen gels used for co-culture were fixed with formalin and embed-
ded in paraffin. Vertical sections with 4 μ m thickness were stained with hematoxylin and eosin (H&E).
CAGE. The details of CAGE library generation and clustering were described previously10. CAGE peaks that 
represent transcription start sites were defined by the decomposition-based peak identification (DPI) method 
and annotated to genes. CAGE peaks associated with the same gene were numbered by the FANTOM5 project, 
according to the number of total read counts9. For example, we named the CAGE peak chr6:45296049 - 45296082, 
+ as “CAGE peak 1 at RUNX2 gene” (p1 RUNX2) since it is the first peak in terms of total read counts within 
the peaks associated with RUNX2. Thus, alternative promoters for the same gene were ranked by their expres-
sion levels, and termed as p1, p2, and p3. CAGE data with raw read counts were obtained from the FANTOM5 
Table Extraction Tool, and were analyzed using the R Bioconductor package ‘edgeR’ for differential expression 
analysis41. CAGE peaks were visualized by the ZENBU browser19. Gene ontology (GO) analysis of differentially 
expressed genes was performed with DAVID web tool42. Classification of non-coding RNAs was performed by 
the annotation of GENCODE19, miTranscriptome, and PLAR43.
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RNA-sequencing. Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). 
RNA-sequencing (RNA-seq) was performed at the Genome Network Analysis Support Facility (GeNAS), RIKEN 
CLST, Yokohama, Japan. For preparing RNA-Seq library, rRNA depletion was performed with 1 μ g total RNA 
using TruSeq Stranded Total RNA with Ribo-Zero GoldKit (Illumina Inc. San Diego, USA). Prepared libraries 
were sequenced with 2 × 100 bp paired-end reads on the Illumina HiSeq 2500 sequencer (Illumina). After quality 
check, raw sequence reads were mapped to the hg19 genome by Tophat (version 2.0.14)44, and visualized with the 
ZENBU browser. The dataset was deposited in the Gene Expression Omnibus database (GSE81870).
Reverse transcription quantitative PCR. Reverse transcription quantitative PCR (RT-qPCR) was per-
formed as previously described45. The quantitative expression was normalized to the transcript levels of glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH). The PCR primers are listed in Supplementary Table S2.
Microarray analyses and Gene Set Enrichment Analysis. Publicly available microarray datasets 
including GSE355112, GSE1909015, and GSE2202916, which analyze transcriptome data of various fibroblasts 
derived from different organs, were used for the validation. The data of GSE19090 and GS22029 were normalized 
using the Robust Multi-array Average algorithm (RMA)46, while the processed data of GSE3551 were downloaded 
directly from the GEO website. The significance analysis of microarrays (SAM) in the R/Bioconductor packages 
was applied for comparison of gene expression between two groups47. Heatmap visualization was performed by 
the EXPANDER 7.0 software package48. Gene Set Enrichment Analysis (GSEA) was performed using the software 
from the Broad Institute GSEAP 2.049 on the large periodontitis microarray dataset which contains samples of 241 
periodontitis and 69 healthy gingival tissues (GSE16134)3.
Loss of function study of DLX5 and RUNX2 long form. Lentivirus vectors carrying artificial 
microRNA sequences were constructed as previously described50. Four pairs of sense and antisense oligonu-
cleotides were designed for targeting human DLX5 and RUNX2 long form, using BLOCK-iT™ RNAi Designer 
(Supplementary Table S2). The annealed oligonucleotides were ligated into the pcDNA6.2-GW/EmGFP-miR 
vector (Life technologies, Carlsbad, CA), subcloned into the entry plasmid pDONR221, and transferred to the 
lentiviral expression vector, pCSII-EF-RfA. The recombinant lentivirus was produced by 293FT cells transfected 
with the lentiviral expression vectors, pCMV-VSV-G-RSV-Rev, and pCAG-HIVgp, using Lipofectamine 2000 
reagent (Life technologies). After 72 h, the medium was collected and 1 × 105 gingival fibroblasts were infected. 
Efficient infection was assessed by detecting EmGFP-positive cells by fluorescence microscope.
Gene expression profiling with cDNA microarray. Total RNA was extracted 5 d after infection of len-
tiviruses which carry negative control (NC) miRNA (miR) or those targeting DLX5 (miR #2 and miR #4) and 
RUNX2 long form (miR #1), using the RNeasy Mini Kit. Microarray analysis was carried out using Affymetrix 
GeneChip® Human Genome U133 Plus 2.0 array, according to the manufacturer’s instructions. Expression values 
less than that of negative control probe were filtered out, and cut-off value of fold change compared to NC was 
set to 0.5 for down- and 2.0 for up-regulated genes. The dataset was deposited in the Gene Expression Omnibus 
database (GSE81870).
Statistical Analysis. Analyses of variance or Student’s t test for unpaired samples was used for statistical 
analysis. The data are expressed as means ± standard deviation (SD), and p < 0.05 was considered statistically 
significant.
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